Current and emerging pharmacological treatments for sarcoidosis: a review
Scott H Beegle,1 Kerry Barba,2 Romel Gobunsuy,1 Marc A Judson1 1Division of Pulmonary and Critical Care Medicine, 2Department of Medicine, Albany Medical College, Albany, NY, USA Abstract: The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or o...
Saved in:
Main Authors: | Beegle SH (Author), Barba K (Author), Gobunsuy R (Author), Judson MA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Inhibition of Chitotriosidase (CHIT1) as a Novel Therapeutic Approach for Sarcoidosis
by: Dymek B, et al.
Published: (2022) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021) -
Sarcoidosis. A review of diagnosis, clinical features and treatment
by: Aleksandra Madej, et al.
Published: (2024) -
Quality of Life and Physical Activity in 629 Individuals With Sarcoidosis: Prospective, Cross-sectional Study Using Smartphones (Sarcoidosis App)
by: Brian Chu, et al.
Published: (2022) -
Pharmacological management of binge eating disorder: current and emerging treatment options
by: McElroy SL, et al.
Published: (2012)